By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Today in CanadaToday in CanadaToday in Canada
Notification Show More
Font ResizerAa
  • Home
  • News
  • Lifestyle
  • Things To Do
  • Entertainment
  • Health
  • Tech
  • Travel
  • Press Release
  • Spotlight
Reading: Health Canada approves 1st needle-free epinephrine treatment for severe allergic reactions
Share
Today in CanadaToday in Canada
Font ResizerAa
  • News
  • Things To Do
  • Lifestyle
  • Entertainment
  • Health
  • Travel
Search
  • Home
  • News
  • Lifestyle
  • Things To Do
  • Entertainment
  • Health
  • Tech
  • Travel
  • Press Release
  • Spotlight
Have an existing account? Sign In
Follow US
Today in Canada > Health > Health Canada approves 1st needle-free epinephrine treatment for severe allergic reactions
Health

Health Canada approves 1st needle-free epinephrine treatment for severe allergic reactions

Press Room
Last updated: 2026/04/15 at 5:37 PM
Press Room Published April 15, 2026
Share
Health Canada approves 1st needle-free epinephrine treatment for severe allergic reactions
SHARE

Listen to this article

Estimated 2 minutes

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results.

Health Canada has approved the first needle-free epinephrine treatment for severe allergic reactions: a nasal spray called Neffy.

ALK Canada, which purchased the rights to distribute the drug, says the two-milligram treatment has been approved for adults and pediatric patients who weigh at least 30 kilograms — roughly 66 lbs.

It says the spray could be on the market as soon as this summer.

As it stands, epinephrine auto-injectors — known by the brand name EpiPen — are the only emergency treatment option available for allergic reactions.

EpiPens are single-use, pre-filled devices used to shoot a dose of epinephrine into the muscle.

Dr. Mariam Hanna, an adjunct clinical professor of pediatrics at Hamilton’s McMaster University, said Neffy’s non-needle delivery system is a plus for those who find it stressful or challenging to deploy auto-injectors.

“We are hoping that people are more ready to use it, and people will use it, in emergencies,” she said in an interview on Wednesday afternoon.

U.S. approved use in 2024

Neffy was approved for use in the United States in summer 2024, where it is also available in a one-milligram dose for kids who weigh 15 to 30 kilograms. That dose has not been approved in Canada.

A news release from ALK Canada says that the Neffy product is pocket-sized and has a shelf life of 30 months from its time of manufacture.

Hanna said Neffy’s emergence means that Canadians will now have more than product they can choose from. That’s also useful in case supply is disrupted, as happened in 2018 with EpiPen auto-injectors.

“It’s great to have more than one option, and it’s fabulous that the other option doesn’t have a needle,” said Hanna.

Food Allergy Canada, a Toronto-based non-profit organization, is applauding the approval of the two-milligram treatment as “an important step forward” that gives Canadians more choices.

Quick Link

  • Stars
  • Screen
  • Culture
  • Media
  • Videos
Share This Article
Facebook Twitter Email Print
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

You Might Also Like

Indigenous patient who sought ER help twice in 2 days was ‘crying’ in pain before she died, inquest hears
Health

Indigenous patient who sought ER help twice in 2 days was ‘crying’ in pain before she died, inquest hears

April 15, 2026
Ottawa ‘very seriously’ considering age restrictions for social media, AI chatbots
Health

Ottawa ‘very seriously’ considering age restrictions for social media, AI chatbots

April 15, 2026
Heather Winterstein’s life possibly could have been saved if treated sooner in Ontario hospital, inquest told
Health

Heather Winterstein’s life possibly could have been saved if treated sooner in Ontario hospital, inquest told

April 14, 2026
Concerns grow as ER in Mission faces its longest stretch of overnight closures yet
Health

Concerns grow as ER in Mission faces its longest stretch of overnight closures yet

April 14, 2026
© 2023 Today in Canada. All Rights Reserved.
  • Privacy Policy
  • Terms of use
  • Advertise
  • Contact
Welcome Back!

Sign in to your account

Lost your password?